市場調查報告書
商品編碼
1503420
到 2030 年質譜軟體市場預測:按類型、部署類型、技術、應用、最終用戶和地區進行的全球分析Mass Spectrometry Software Market Forecasts to 2030 - Global Analysis By Type, Deployment Type, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球質譜軟體市場規模將達到 63 億美元,預計到 2030 年將達到 126 億美元,預測期內複合年成長率為 10.3%。
質譜軟體是指設計用於分析質譜儀產生的資料的電腦程式。這些工具透過根據質荷比識別和量化分子來幫助解釋複雜的頻譜。它們通常包括資料處理、峰值檢測、分子結構闡明和統計分析等功能,這些功能對於蛋白質組學、代謝體學和環境分析等應用至關重要。此類軟體有助於從原始質譜資料中高效、準確地提取有意義的資訊,在現代科學研究中發揮重要作用。
據製造商稱,最新的質譜儀比其前身小 45%,並且使用的天然氣和電力減少了 50%。
個人化醫療需求不斷成長
對個人化醫療解決方案的需求正在迅速成長。技術的進步使得軟體能夠更準確地分析個別患者的資料,從而更容易制定量身定做的治療計劃。這一趨勢反映了向精準醫療的轉變,精準醫療在根據患者俱體特徵最佳化藥物療效和最大限度減少副作用方面發揮關鍵作用。隨著醫療保健產業接受個人化醫療,市場預計將大幅成長,以滿足這些不斷變化的需求。
缺乏熟練的專業人員
市場面臨一個重大挑戰:缺乏能夠有效利用先進分析工具並解釋複雜資料輸出的熟練專業人員。這種不足阻礙了產業創新和最佳化軟體解決方案以滿足不斷變化的科學需求的能力。隨著對準確性和可靠性的要求不斷提高,彌合這一技能差距對於釋放質譜技術在研究、製藥和環境分析領域的全部潛力至關重要。
質譜技術的進步
質譜軟體的最新進展透過提高靈敏度、解析度和分析速度徹底改變了市場。創新技術包括即時資料處理、複雜資料解釋的改進演算法以及與人工智慧的整合以進行預測分析。這些發展使得我們能夠更深入地了解分子結構、更快地識別化合物以及在製藥、環境分析和蛋白質組學等各種應用中更準確地進行定量。
資料複雜度
質譜分析會產生大量結構複雜、高維度的資料,需要複雜的軟體解決方案來進行準確的分析和解釋。挑戰包括處理不同的資料格式、與不同的儀器平台整合以及確保資料處理和可視化的強大演算法。解決這些複雜性對於增強資料驅動的洞察力、提高分子鑑定的準確性以及推進蛋白質組學、代謝體學和臨床診斷等領域的應用至關重要。
COVID-19 大流行對市場產生了重大影響,實驗室面臨業務中斷和研究計劃延遲的問題。儘管最初遇到了挫折,但市場適應了對遠端功能和資料分析工具日益成長的需求。基於雲端基礎的解決方案和虛擬協作的創新已經出現,以推動復甦和成長。這些公司正在轉向提高效率和擴充性的軟體解決方案,這反映出該行業在全球健康挑戰中的技術整合和遠端工作能力方法中出現的彈性。
脂類組學領域預計將成為預測期內最大的市場。
脂類組學預計將是預測期內規模最大的。軟體解決方案對於資料處理、脂質識別和質譜資料定量至關重要。該市場的主要參與者專注於開發方便用戶使用的介面、開發用於脂類組學資料解釋的強大演算法以及與現有分析工作流程整合。隨著脂類組學在生物醫學研究和臨床診斷中的地位日益突出,解決脂質分析複雜性的技術創新預計將進一步擴大市場。
食品和飲料產業預計在預測期內複合年成長率最高
食品和飲料行業預計在預測期內複合年成長率最高。這些工具對於確保食品安全、品管和遵守監管標準至關重要。能夠準確分析污染物、添加劑和營養成分,進而提高產品完整性和消費者信心。隨著公司優先考慮流程的效率和準確性,市場持續成長。
在分析技術進步以及製藥、生物技術和環境科學研究不斷增加的推動下,預計北美在預測期內將佔據最大的市場佔有率。主要企業主導市場,提供複雜的軟體解決方案,提高分析能力和資料處理效率。該地區對研發的大力投資以及對精準醫療和個人化醫療保健的關注正在推動對先進質譜軟體解決方案的需求,並進一步推動市場擴張。
預計亞太地區在預測期內將維持最高的複合年成長率。由於醫療成本上升、慢性病盛行率增加以及人口老化,醫療保健產業正在迅速擴張。質譜廣泛應用於臨床診斷、生物標記發現和藥物開發,形成相關軟體解決方案的重要市場。該地區各國政府支持旨在提高科學研究能力和促進創新的舉措。
According to Stratistics MRC, the Global Mass Spectrometry Software Market is accounted for $6.3 billion in 2024 and is expected to reach $12.6 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Mass spectrometry software refers to computer programs designed to analyze data generated by mass spectrometry instruments. These tools aid in the interpretation of complex spectra by identifying and quantifying molecules based on their mass-to-charge ratios. They often include features for data processing, peak detection, molecular structure elucidation, and statistical analysis, crucial for applications in proteomics, metabolomics, and environmental analysis. Such software plays a vital role in modern scientific research, facilitating the extraction of meaningful information from raw mass spectrometry data efficiently and accurately.
According to the manufacturer, its most recent mass spectrometer is 45% smaller and uses up to 50% less gas and electricity than its predecessor while being up to 15X more sensitive for assessing negatively ionizing chemicals.
Growing demand for personalized medicine
The market is experiencing a surge in demand for personalized medicine solutions. Advances in technology have enabled software to analyze individual patient data more accurately, facilitating tailored treatment plans. This trend reflects a shift towards precision healthcare, where it plays a crucial role in optimizing drug effectiveness and minimizing side effects based on patient-specific characteristics. As the healthcare industry embraces personalized medicine, the market is expected to grow significantly to meet these evolving needs.
Lack of skilled professionals
The market faces a significant challenge due to a shortage of skilled professionals capable of effectively utilizing advanced analytical tools and interpreting complex data outputs. This shortage hinders the industry's ability to innovate and optimize software solutions tailored to evolving scientific needs. As demand for precision and reliability grows, bridging this skills gap becomes crucial for maximizing the potential of mass spectrometry technologies in research, pharmaceuticals, and environmental analysis sectors.
Technological advancements in mass spectrometry
Recent advancements in mass spectrometry software have revolutionized the market by enhancing sensitivity, resolution, and speed of analysis. Innovations include real-time data processing, improved algorithms for complex data interpretation, and integration with artificial intelligence for predictive analytics. These developments enable deeper insights into molecular structures, faster identification of compounds, and more precise quantification in various applications such as pharmaceuticals, environmental analysis, and proteomics.
Data complexity
Mass spectrometry generates vast amounts of data with intricate structures and high dimensionality, requiring sophisticated software solutions for accurate analysis and interpretation. Challenges include handling diverse data formats, integrating with various instrumentation platforms, and ensuring robust algorithms for data processing and visualization. Addressing these complexities is crucial for enhancing data-driven insights, improving accuracy in molecular identification, and advancing applications in fields like proteomics, metabolomics, and clinical diagnostics.
The COVID-19 pandemic significantly impacted the market as laboratories faced operational disruptions and delays in research projects. Despite initial setbacks, the market adapted with increased demand for remote capabilities and data analysis tools. Innovations in cloud-based solutions and virtual collaborations emerged, driving recovery and growth. Companies pivoted towards software solutions enhancing efficiency and scalability, reflecting a resilient shift in the industry's approach to technological integration and remote work capabilities amidst global health challenges.
The lipidomics segment is expected to be the largest during the forecast period
The lipidomics is expected to be the largest during the forecast period. Software solutions are crucial for data processing, lipid identification, and quantification from mass spectrometry data. Key players in this market focus on developing user-friendly interfaces, robust algorithms for lipidomic data interpretation, and integration with existing analytical workflows. As lipidomics gains prominence in biomedical research and clinical diagnostics, the market is expected to expand further with innovations addressing the complexities of lipid analysis.
The food and beverage industry segment is expected to have the highest CAGR during the forecast period
The food and beverage industry segment is expected to have the highest CAGR during the forecast period. These tools are integral for ensuring food safety, quality control, and compliance with regulatory standards. They enable precise analysis of contaminants, additives, and nutritional components, thereby enhancing product integrity and consumer confidence. The market sees continuous growth as companies prioritize efficiency and accuracy in their processes.
North America is projected to hold the largest market share during the forecast period driven by advancements in analytical techniques and increasing research in pharmaceuticals, biotechnology, and environmental sciences. Key players dominate the market, offering sophisticated software solutions that enhance analytical capabilities and data processing efficiency. The region's strong investment in research and development further fuels market expansion, with a focus on precision medicine and personalized healthcare driving demand for advanced mass spectrometry software solutions.
Asia Pacific is projected to hold the highest CAGR over the forecast period. The healthcare industry is expanding rapidly due to rising healthcare expenditure, increasing chronic diseases, and a growing aging population. Mass spectrometry is widely used in clinical diagnostics, biomarker discovery, and drug development, creating a significant market for related software solutions. Governments across the region are supporting initiatives aimed at enhancing scientific research capabilities and fostering innovation.
Key players in the market
Some of the key players in Mass Spectrometry Software market include Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, Bruker Corporation, Shimadzu Corporation, PerkinElmer, JEOL Ltd, Bio-Rad Laboratories, LECO Corporation, Advion, Peak Scientific Instruments, Rigaku Corporation, AMETEK Process Instruments, Hitachi High-Technologies Corporation, Pfeiffer Vacuum, Oxford Instruments and Teledyne CETAC Technologies.
In June 2023, Agilent Technologies Inc. announced two new liquid chromatography mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TOF. Facilitating the high-end performance of the Revident LC/Q-TOF, Agilent is also announcing the new Agilent MassHunter Explorer Profiling software and the new Agilent ChemVista library manager software.
In August 2023, Thermo Fisher Scientific has announced the commercial launch of the EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma which, according to the World Health Organisation in 2020, is the second most prevalent blood cancer worldwide.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.